SOURCE: Pro-Pointer, Inc.

August 24, 2010 09:00 ET

Pro-Pointer, Inc. Introduces a Revolutionary Supplement for Stress and Anxiety

LAS VEGAS, NV--(Marketwire - August 24, 2010) - Pro-Pointer, Inc. (PINKSHEETS: PPII), through its wholly-owned subsidiary Coenzyme-A Technologies, Inc., proudly announces today the introduction of their latest Nutraceutical development, the "MODULATOR MATRIX I" formula, especially designed to help the individual user to effectively cope with today's Stress and Anxiety Syndromes.

According to an American Psychological Association (APA) recent study, a total of 43% of adults in the U.S. suffer adverse health effects from stress. The National Institute of Mental Health reports that Anxiety disorders affect approximately 40 million American adults age 18 years or older. That clearly translates to 18% of the population in a given year. Stress is a psychological response to an external happening, whereas anxiety is a state of mind that is real or imagined and manifests itself in physical symptoms like rapid heart rate and sweaty palms, sleeping disorders and eventually depression.

Nickolaos D. Skouras, Ph.D., the President of Coenzyme-A Technologies, Inc., explains that both stress and anxiety can cause a cascade of biological reactions that occur in the brain. It is an over stimulation of the Hypothalamic-Pituitary-Adrenal axis, which over time can damage the immune system and cause a host of health issues. Current studies also show that the metabolic enzyme (Coenzyme-A) plays a major role in the body's ability to cope with stress, anxiety, and depression and further strengthen the immune system. During the process of combating stress and anxiety, the human body secretes hormones as a means to adapt to the ever increasing daily stress levels. These hormones are derivatives of cholesterol and an increased demand for the synthesis of them by the human body will prioritize and draw on the remaining available Coenzyme-A pool, thus rendering a state of deficiency.

The market value of this revolutionary supplement for stress and anxiety becomes readily apparent with the out-of-pocket costs and undesirable side-effects of Anti-Depressant prescriptive medicine skyrocketing, unemployment rates at all time highs and access to affordable health care unavailable. Consumers are now turning to preventative OTC solutions and remedies to stave off illness, manage chronic injury and disease and promote overall health and well-being. Market acceptance of natural products and herbal dietary supplements is ever-growing as consumers pursue healthier, eco-friendly lifestyles.

Coenzyme-A Technologies, Inc. has independently developed the proprietary Coenzyme-A nutraceutical product "MODULATOR Matrix I" that naturally addresses hormonal imbalances. Chemical imbalance within the body and nutritional deficiencies that result from Stress and Anxiety disorders and the deleterious effects of Aging.

Based on the above facts, this latest Coenzyme-A development, "Modulator Matrix I," and upon being properly marketed well, represents annual gross sales of several million dollars.

ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- www.coenzyme-a.com.

FORWARD-LOOKING STATEMENTS
The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information

  • Contact Information:
    Pro-Pointer, Inc.
    458 Coral Sea St.
    Henderson, Nv. 89074
    Ph- 702-458-4111
    Cell-702-591-7440